Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection

体外培养的源自循环单核细胞的人原代巨噬细胞包含黏附型和非黏附型亚群,二者在Siglec-1和CD4的表达以及对HIV-1感染的易感性方面存在差异。

阅读:1

Abstract

Macrophages are a major target for human immunodeficiency virus type 1 (HIV-1) infection. However, macrophages are largely heterogeneous and may exhibit differences in permissiveness to HIV-1 infection. This study highlights the interplay of macrophage heterogeneity in HIV-1 pathogenesis. We show that monocyte-derived macrophages (MDMs) could be divided into two distinct subsets: CD14(+)Siglec-1(hi)CD4(+) (non-adherent MDM) and CD14(+)Siglec-1(Lo)CD4(-) (adherent MDM). The CD14(+)Siglec-1(hi)CD4(+)MDM subset represented the smaller proportion in the macrophage pool, and varied among different donors. Fractionation and subsequent exposure of the two MDM subsets to HIV-1 revealed opposite outcomes in terms of HIV-1 capture and infection. Although the CD14(+)Siglec-1(hi)CD4(+)MDM captured significantly more HIV-1, infection was significantly higher in the CD14(+)Siglec-1(Lo)CD4(-)MDM subset. Thus, CD14(+)Siglec-1(hi)CD4(+)MDM were less permissive to infection. Depletion of CD14(+)Siglec-1(hi)CD4(+)MDM or a decrease in their percentage, resulted in increased infection of MDM, suggestive of a capacity of these cells to capture and sequester HIV-1 in an environment that hinders its infectivity. Increased expression of innate restriction factors and cytokine genes were observed in the non-adherent CD14(+)Siglec-1(hi)CD4(+)MDM, both before and after HIV-1 infection, compared to the adherent CD14(+)Siglec-1(Lo)CD4(-)MDM. We speculate that the differential expression of gene expression profiles in the two macrophage subsets may provide an explanation for the differences observed in HIV-1 infectivity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。